Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael A. Gonzalez
AddedFeb 15, 2024
UpdatedJun 26, 2026
Michael A. Gonzalez

Michael A. Gonzalez

Founder, Palus Finance

Crunchbase

Michael A. Gonzalez's Career

Palus Finance
Palus Finance

Brooklyn, NY, US

Founder
Bright Path Laboratories
Bright Path Laboratories

Kannapolis, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael A. Gonzalez's Career

Palus Finance
Palus Finance
Brooklyn, NY, US
Founder

Similar to Palus Finance

TreasureTreasureRichardson, TX, USCash Management, Financial Management, Financial Technologyest. 2021TreasureRichardson, TX, US · est. 2021

Treasure: A secure cash management platform transforming idle business funds into revenue.

Series A · $14M42
WellspringWellspringLos Angeles, CA, USWellspringLos Angeles, CA, US

Consumer app that converts bank deposits into stablecoin-powered high-yield savings.

Pre-Seed · $20k
ArpariArpariNew York City, NY, USTreasury Managementest. 2022ArpariNew York City, NY, US · est. 2022

Arpari: Streamlining CRE finances with a unified treasury management platform.

Pre-Seed · $500k5
JutsooJutsooFinancial Managementest. 2021Jutsooest. 2021

Streamline all bank accounts with Jutsoo's treasury management platform.

Pre-Seed · $500k12
Bright Path Laboratories
Bright Path Laboratories
Series A$8.5M232019Kannapolis, NC, US
Board Member· Board

Leadership at Bright Path Laboratories

Tony QuinonesTony QuinonesBoard Member
Phil LichtenbergerPhil LichtenbergerBoard Member

Similar to Bright Path Laboratories

Continuity PharmaContinuity PharmaWest Lafayette, IN, USManufacturing Systemsest. 2018Continuity PharmaWest Lafayette, IN, US · est. 2018

Continuity Pharma: Modern, efficient systems for manufacturing essential generic medicines.

Seed · $1.5M9
Brighton BiotechBrighton BiotechFort Worth, TX, USBiotech Drugs, Pharmaceuticalsest. 2010Brighton BiotechFort Worth, TX, US · est. 2010

US-based Brighton Biotech manufactures pharmaceutical and biotech drugs for human and veterinary use.

Public · $1.6M5
PhlowPhlowRichmond, VA, USMedications, Pharmaceuticalsest. 2020PhlowRichmond, VA, US · est. 2020

Phlow: U.S.-based manufacturer of affordable, quality essential medications.

Series B · $80.2M60
ResilienceResilienceLos Angeles, CA, USBiopharmaceuticals, Manufacturingest. 2020ResilienceLos Angeles, CA, US · est. 2020

Resilience, Inc.: A pioneering tech-manufacturing firm ensuring access to complex medicines and safeguarding biopharma supply chains.

Late Stage Private · $2.5B2k

People Similar to Michael A. Gonzalez

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao